Modeling Heterogeneity of Triple‐Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance

Autor: Ulrike A. Köhler, Vincent Géli, Fahmida Ahmad, Fabrice Daian, Emmanuelle Josselin, Rémy Castellano, Sima Lev, Gordon B. Mills, Anna Katharina Müller, Christelle Cayrou, Olivier Castellanet, Jean-Paul Borg, Fabienne Lamballe, Yaron Vinik, Emmanuelle Charafe-Jauffret, Anne-Laure Bailly, Flavio Maina

Publikováno v: Advanced Science
Advanced Science, 2020, pp.2003049. ⟨10.1002/advs.202003049⟩
Advanced Science, 2021, 8 (3), pp.2003049. ⟨10.1002/advs.202003049⟩
Advanced Science, Vol 8, Iss 3, Pp n/a-n/a (2021)
Advanced Science, Wiley Open Access, 2020, pp.2003049. ⟨10.1002/advs.202003049⟩

Triple‐negative breast cancer (TNBC) is a highly aggressive breast cancer subtype characterized by a remarkable molecular heterogeneity. Currently, there are no effective druggable targets and advanced preclinical models of the human disease. Here,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a4928f8e7a9413913a642e3fddc91ba
https://hal.science/hal-03102695

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.